EVGN - Evogene Ltd.

0.8185
-0.001   -0.183%

Share volume: 244,576
Last Updated: 03-27-2026
Chemicals/Agriculture Chemicals: -0.02%

PREVIOUS CLOSE
CHG
CHG%
$0.82
0.00
0.00%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
6%
Profitability 0%
Dept financing 6%
Liquidity 50%
Performance 0%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
-12.43%
1 Month
-5.27%
3 Months
-15.65%
6 Months
-30.64%
1 Year
-37.52%
2 Year
9.13%
Key data
Stock price
$0.82
P/E Ratio 
0.00
DAY RANGE
$0.79 - $0.92
EPS 
-$0.76
52 WEEK RANGE
$0.73 - $2.42
52 WEEK CHANGE
-$34.52
MARKET CAP 
16.642 M
YIELD 
N/A
SHARES OUTSTANDING 
5.058 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
05-22-2025
BETA 
0.93
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$185,277
AVERAGE 30 VOLUME 
$176,011
Company detail
CEO: Ofer Haviv
Region: US
Website: evogene.com
Employees: 140
IPO year: 2008
Issue type: Common Stock
Market: XNAS
Industry: Chemicals/Agriculture Chemicals
Sector: Manufacturing

Evogene Ltd. focuses on product discovery and development in multiple life-science based industries, including human health and agriculture. It operates through three segments: Agriculture, Human Health, and Industrial Applications. The company has strategic collaborations and licensing agreements with agricultural companies, such as BASF SE, Corteva, and Bayer.

Recent news